NeuroX, an online consultation service specializing in neurology, and its physician network ATP Partners announced that they will join the Centers for Medicare and Medicaid Services (CMS) GUIDE program to enhance care for patients with dementia.
NeuroX, the brain health division of American TelePhysician, provides a virtual care platform that connects individuals with neurologists, psychiatrists, and sleep specialists, providing what the company touts as a „complete brain health ecosystem.“
The company works with employers, individuals, and facilities to offer online screening and consultation, neurodiagnostics, AI-powered remote patient monitoring, and an audio-based cognitive assessment test called LANGaware.
CMS” guide programofficially launched on July 1 and aims to support people with dementia and their carers by providing care coordination and care management services, respite services, and carer education and support. . Also, individuals can access her 24/7 support line.
Additionally, the program will provide guidelines for a standard approach to care aimed at allowing people with dementia to continue living at home.
Through the GUIDE program, people living with dementia will have access to a technology platform that includes NeuroX and ATP's diagnostic, treatment and home care services.
“GUIDE is the latest innovative CMS value-based program focused on improving clinical quality while reducing Medicare healthcare costs,” ATP CFO David Spalding said in a statement. .
“As a GUIDE participant, ATP will deploy our award-winning, scalable brain health care management platform, partner with community-based physician groups focused on older adults with chronic conditions, and provide our own expert Supports telemedicine networks.”
bigger trends
CMS announced the GUIDE model in July last year. President Biden's Executive Order Published three months ago to increase access to quality care and support carers.
According to the CDCApproximately 5.8 million people in the United States have Alzheimer's disease or another type of dementia, and that number is expected to jump to 14 million by 2060.
Other organizations focused on providing dementia care include Japanese pharmaceutical companies Eisai and Oita University,Japan also, We built an AI model It uses data from wearable devices to predict Alzheimer's disease, the most common form of dementia.
Based in St. Louis harmonic health This is another technology-enabled dementia care platform. Fujifilm Co., Ltd.Which Developed AI technology Predicting whether patients with mild cognitive impairment will progress to Alzheimer's disease within 2 years.